CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 122 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $830,541 | +0.9% | 18,543 | +5.4% | 0.01% | 0.0% |
| Q1 2024 | $823,154 | +56.4% | 17,585 | +18.9% | 0.01% | +50.0% |
| Q4 2023 | $526,193 | +17.4% | 14,789 | -1.9% | 0.00% | 0.0% |
| Q3 2023 | $448,182 | +134.7% | 15,070 | +42.2% | 0.00% | +100.0% |
| Q2 2023 | $190,994 | +9.0% | 10,599 | -2.9% | 0.00% | 0.0% |
| Q1 2023 | $175,279 | -9.8% | 10,914 | +2.8% | 0.00% | 0.0% |
| Q4 2022 | $194,291 | -2.9% | 10,617 | +4.3% | 0.00% | 0.0% |
| Q3 2022 | $200,000 | +6.4% | 10,178 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $188,000 | -23.9% | 10,078 | +15.9% | 0.00% | 0.0% |
| Q4 2021 | $247,000 | – | 8,693 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 479,681 | $21,484,912 | 8.12% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $6,315,390 | 7.68% |
| STEMPOINT CAPITAL LP | 551,095 | $24,683,545 | 7.25% |
| EcoR1 Capital, LLC | 4,155,375 | $186,119,246 | 5.69% |
| ACUTA CAPITAL PARTNERS, LLC | 135,141 | $6,052,965 | 5.10% |
| First Light Asset Management, LLC | 1,200,508 | $53,770,753 | 4.71% |
| Ikarian Capital, LLC | 588,818 | $26,373,158 | 4.59% |
| Paradigm Biocapital Advisors LP | 2,513,302 | $112,570,797 | 4.31% |
| MPM BioImpact LLC | 557,184 | $24,956,271 | 3.88% |
| Cormorant Asset Management, LP | 1,350,000 | $60,466,500 | 3.49% |